Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16413416 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Randomized Controlled Trial of Silymarin in Asthma
Condition: Atopic Asthma
Interventions: Drug: Oral Silymarin;   Drug: Oral Silymarin, maintenance dose;   Drug: Placebo
2 Active, not recruiting The Effect of Protandim Supplementation on Oxidative Damage and Athletic Performance
Condition: Oxidative Damage
Intervention: Dietary Supplement: Protandim Dietary Supplement

Indicates status has not been verified in more than two years